SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-013642
Filing Date
2020-05-29
Accepted
2020-05-29 08:00:32
Documents
2
Period of Report
2020-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea122440-8k_hoththerapeutics.htm 8-K 26576
2 MEMBERSHIP INTEREST PURCHASE AGREEMENT BY AND BETWEEN THE COMPANY AND HALOVAX, L ea122440ex10-1_hoththerap.htm EX-10.1 45694
  Complete submission text file 0001213900-20-013642.txt   73379
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 20924061
SIC: 2834 Pharmaceutical Preparations